A prevailing thought around election time is whether or not the market will see significant shifts, depending on the outcome. There’s also a matter of how this continues to factor into uncertainty, let alone what benefits come from making stimulus-related decisions before or after the election. That in mind, during CNBC’s “Halftime Report,” there were [...] Read more at ETFtrends.com.
Tarsus Pharmaceuticals, a Phase 3 biotech developing therapies for ophthalmic conditions, announced terms for its IPO on Friday.
The Irvine, CA-based company plans to raise $80 million by offering 5 million shares at a price range of $15 to $17. At the midpoint of the proposed ra
Aligos Therapeutics, a Phase 1 biotech developing oligonucleotide therapies for viral and liver diseases, announced terms for its IPO on Friday.
The South San Francisco, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At
Eargo, which manufactures differentiated hearing aid systems, announced terms for its IPO on Friday.
The San Jose, CA-based company plans to raise $100 million by offering 6.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Eargo would comman
Carney Technology Acquisition II, a blank check company targeting the technology industry, filed on Friday with the SEC to raise up to $350 million in an initial public offering.
The Burlingame, CA-based company plans to raise $350 million by offering 35 million units at $10
Ireland's budget deficit is set to hit 6.1% of gross domestic product this year, Finance Minister Paschal Donohoe said on Friday, a narrower than forecast shortfall likely to give him room for more generous measures in Tuesday's budget.
U.S. aviation contractors laid off thousands of workers due to delays in payroll aid from the U.S. Treasury that was meant to protect jobs, an investigation by a U.S. House of Representatives subcommittee found.
Seven IPOs and 10 SPACs went public this past week. The IPO pipeline remained active, with eight IPOs and seventeen SPACs submitting initial filings.
Phase 2 biotech Kronos Bio (KRON) priced above the range to raise $250 million at a $1.1 billion market cap. The biotech is devel
Human Rights Watch wants the city of Buenos Aires to stop using live facial recognition to identify children accused of committing crimes, the rights group said on Friday.
In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Jim Gillies about the latest headlines and earning reports from Wall Street. They look at the latest earning report of a jeans company and discuss its strategy and spillover gains to other retailers. The
The United States Olympic and Paralympic Committee (USOPC) said on Friday it has filed a lawsuit against its insurance providers for failing to fulfill obligations in reaching a settlement with survivors of the Larry Nassar sexual abuse scandal.
A blank-check company backed by private equity firm Apollo Global Management Inc said on Friday it was looking to raise $400 million in a U.S. initial public offering.
Opthea, an Australian Phase 3 biotech developing VEGF inhibitors for wet AMD, announced terms for its IPO on Friday.
The South Yarra, Australia-based company plans to raise $161 million by offering 9.3 million ADSs at $17.26, the as-converted last close of its shares on the ASX (
A group of leasing companies has rejected a restructuring plan put forward by Malaysia Airlines, bringing the carrier closer to a showdown over its future.
The market closed out its best week in months Friday, with the S&P 500 now up 4% in the last four weeks, as it regains momentum from its early September drop. The positivity comes as Wall Street grows more hopeful about the possibility of a second stimulus bill, perhaps befo
The union of workers at Chile´s Collahuasi copper mine has come to an agreement in labor talks with the mine operator, the union president said on Friday, staving off the threat of a strike at the sprawling deposit.
Friday closed the week on a positive note for the stock market, with market participants seeing no reason to curb their enthusiasm about the future. With Washington politicians once more getting close to making a deal for more economic support, and with most investors perfectly
Shares of telehealth start-up Amwell (NYSE: AMWL) have risen sharply since the company made its public stock-market debut in September. The most recent spike was fueled by speculation that UnitedHealth Group (NYSE: UNH) was eager to acquire the company despite its surging market
U.S. Department of Health and Human Services on Friday signed an agreement with AstraZeneca Plc for development and supply of the company's COVID-19 antibody treatment, a cocktail of two monoclonal antibodies - similar class of drugs that was administered to President Donald Trump.